Global Immuno-Oncology Assay Market is expected to reach USD 18.1 billion by 2034

The global immuno-oncology assay market is estimated to be worth USD 5.6 billion in 2024 and is projected to be valued at USD 18.1 billion in 2034. Between 2024 and 2034, the industry is expected to register a CAGR of 12.4%.

The increasing adoption of immunotherapy in cancer treatment is driving the demand for immuno-oncology assays. These assays are crucial for assessing the efficacy of immunotherapeutic agents, predicting patient responses, and monitoring treatment outcomes.

There is a growing emphasis on biomarker-driven approaches in cancer care, leading to the discovery of novel biomarkers associated with immunotherapy response. Immuno-oncology assays play a critical role in identifying predictive and prognostic biomarkers, and facilitating personalized treatment strategies.

Burgeoning investments in immuno-oncology research and clinical trials is driving market growth. Pharmaceutical companies, biotechnology firms, and academic institutions are conducting extensive research to develop novel immunotherapies and validate immuno-oncology assays in clinical settings.

Favorable regulatory frameworks and reimbursement policies for immuno-oncology assays are facilitating market growth. Regulatory approvals and reimbursement coverage increase the adoption of immuno-oncology assays in clinical practice, driving market expansion.

Key Takeaways from the Market Study

  • From 2019 to 2023, the immuno-oncology assay market expanded at a CAGR of 15.4%.
  • Based on technology, the Checkpoint Inhibitors segment is expected to rise at a CAGR of 11.9% during the forecast period.
  • The immuno-oncology assay demand in South Korea is predicted to flourish at a CAGR of 15.2% through 2034.
  • In the United States, the immuno-oncology assay industry is estimated to register a CAGR of 12.1% from 2024 to 2034.
  • The United Kingdom is projected to expand by a CAGR of 13.9% between 2024 and 2034.
  • The immuno-oncology assay market in Japan is anticipated to record a CAGR of 14.1% during 2034.

“The growing acceptance and utilization of immunotherapy across various cancer types drive the demand for immuno-oncology assays, fueling market growth,” says an FMI analyst.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Competitive Landscape

Key players in the sector have fortified their global market positions through the adoption of innovative products and substantial research and development endeavors. As competition intensifies, numerous companies are directing their efforts toward research and the introduction of new diagnostic methodologies, expanding their product lines, and pursuing acquisitions and mergers.

  • Bio-Rad Laboratories provides a wide range of life science research tools, including instruments, reagents, and assays for genomics, proteomics, and cell biology. Its offerings support various aspects of immuno-oncology assay development and validation.
  • Hoffmann-La Roche Ltd. is a leading provider of diagnostics and pharmaceuticals, offering companion diagnostics for immuno-oncology therapies, as well as research tools and assays for biomarker discovery and validation.
  • PerkinElmer offers a range of solutions for immuno-oncology research, including imaging systems, high-content screening platforms, and reagents for cellular and molecular analysis.

Key Companies Profiled:

AGILENT TECHNOLOGIES; Sartorius AG; NanoString Technologies; THERMO FISHER SCIENTIFIC; BIO-RAD LABORATORIES; F. HOFFMANN-LA ROCHE LTD.; PERKINELMER; ILLUMINA; QIAGEN N.V.; Charles River Laboratories

Immuno Oncology Assay Market – Key Segments

By Product:

  • Reagents and Antibodies
  • Instruments
  • Software
  • Consumables and Accessories

By Technology:

  • Checkpoint Inhibitors
  • Cytokines & Immunomodulators
  • Monoclonal Antibodies
  • Other Technologies

By indication:

  • Melanoma
  • Colorectal Cancer
  • Lung Cancer
  • Other Cancers

By End-User:

  • Hospitals
  • Clinics
  • Cancer Research Centers

By Application:

  • Research Applications
  • Clinical Diagnostics

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Carrier Screening Market Set to Grow at a Robust CAGR of 12.4%, Projected to Reach USD 4,323.84 Million by 2033

The global carrier screening market is expected to experience significant growth, with a projected compound annual growth rate (CAGR) of 12.4% from 2023 to 2033. Estimated at USD 1,343.40 million in 2023, the market is anticipated to reach USD 4,323.84 million by 2033, driven by increasing demand for genetic testing, advancements in diagnostic technologies, and expanding funding from both public and private sectors.

Rising Demand for Genetic Testing Fuels Market Expansion:

The growing prevalence of genetic defects and chronic diseases has heightened the demand for carrier screening, making genetic testing a crucial tool for early diagnosis and prevention. Increased investments in healthcare and diagnostics are further propelling market growth, particularly with the introduction of innovative tests designed to enhance diagnosis and treatment.

As technology becomes more accessible, the adoption of carrier screening tests is expected to accelerate, providing better outcomes for individuals and families at risk for inherited genetic disorders.

Strategic Mergers, Acquisitions, and Innovations Drive Market Dynamics:

Industry players are strengthening their positions through strategic mergers, agreements, and acquisitions. In a notable move, Counsyl, Inc. expanded its partnership with Angsana Molecular & Diagnostics Laboratory in 2017 to sell the Extended Carrier Screening (ECS) test in Hong Kong. Subsequently, Myriad Genetics, Inc. acquired Counsyl in 2018, enhancing its portfolio of genetic tests.

Furthermore, the launch and approval of new carrier screening tests are expected to play a key role in fueling market expansion in the coming years.

Regional Insights: North America Leads, Europe Follows Suit

North America is set to maintain its dominance in the carrier screening market, driven by the approval of new products and the introduction of innovative genetic tests. A prime example is Sema4’s announcement in October 2019 of the availability of the Expanded Carrier Screen, a test that helps estimate the likelihood of a child inheriting a genetic condition.

Europe is also seeing strong growth, with the launch of cutting-edge screening tests such as QIAGEN’s QIAseq Expanded Carrier Screening Panel in June 2019. This test, which offers insight into genes associated with 200 disease indications, marks a significant milestone in molecular diagnostics.

The continued development of novel tests and increased adoption of carrier screening technologies are expected to sustain the market’s upward trajectory, benefiting both healthcare providers and patients worldwide.

Key Takeaways:

  • With a 12.9% CAGR between 2023 and 2033, the expanded carrier screening (ECS) segment is anticipated to be the key revenue-generating market.
  • Through 2033, the DNA sequencing market sector held a 39.9% revenue share, dominating the carrier screening market.
  • With a 47.1% carrier screening market share throughout the projection period, the laboratory segment dominated the global market.
  • With a share of 40.19% through 2033, the North American market is anticipated to hold a leading position in the carrier screening market.

Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!

Competitive Landscape:

There are several significant participants in the fragmented and competitive carrier screening market. A small number of significant businesses control a large portion of the market.

The market’s overall competitive rivalry is growing as a result of the existence of significant players including Abbott, F. Hoffmann-La Roche AG, Danaher Corporation (Cepheid), Illumina Inc., and Thermo Fisher Scientific Inc.

Recent Development:

Collaboration – To Co-develop:

Illumina and Kartos Therapeutics, Inc. announced a collaboration to co-develop a TP53 companion diagnostic (CDx) in April 2021. This CDx is based on the information provided by Illumina’s comprehensive genomic profile assay, TruSight Oncology.

Partnership – Utilizing the Skills of Both Parties:

Fulgent and Precision Genomics Laboratory (PGL) partnered in January 2019 to offer Columbia patients on-site performed, expanded carrier screening.

Acquisition – For Expansion:

Fulgent purchased CSI Laboratories (CSI) in August 2021 to increase its exposure to somatic molecular diagnostics and cancer testing. CSI provides molecular genetics, immunohistochemistry, fluorescence in-situ hybridization (FISH), and cytogenetic studies.

Key Players:

  • Myriad Genetics, Inc
  • Cepheid
  • Illumina
  • Thermo Fisher Scientific Inc.
  • F.Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • Otogenetics
  • MedGenome
  • GeneTech
  • Centogene N.V.

Key Segments:

By Type:

  • Expanded Carrier Screening
  • Targeted Disease Carrier Screening

By Medical Condition:

  • Cystic Fibrosis
  • Tay-Sachs
  • Gaucher Disease
  • Sickle Cell Disease
  • Spinal Muscular Atrophy
  • Other

By Technology:

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Other

By End User:

  • Hospitals
  • Laboratories
  • Physician Offices & Clinics
  • Other

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Increasing Awareness of Animal Welfare to Amplify Veterinary Antibiotics Market; FMI Analysts Predict Market Valuation to Surpass USD 20,154 Million by 2033

The veterinary antibiotics market size is anticipated to surpass USD 11,453.3 million in 2023 and is likely to attain a valuation of USD 20,154.0 million by 2033. The veterinary antibiotics market share is projected to thrive at a CAGR of 5.8% from 2023 to 2033.

An increase in households owns dogs, cats, and other companion animals. Demand for veterinary treatment, particularly the administration of antibiotics, has risen as pet owners try to protect the health and well-being of their animals. Animal welfare knowledge and concerns are increasing on a global level, which has prompted more focus on preventing and diagnosing animal illnesses. This emphasis on the health and welfare of animals promotes the demand for veterinary antibiotics as a component of comprehensive disease control methods, which subsequently amplifies market growth.

Investments in the field of animal healthcare have increased as the significance of animal health is more recognized. New veterinary antibiotics and associated medicines are being developed with funding from pharmaceutical corporations and research organizations, which encourages market expansion.

Growing food quality safety, concerns are likely to proliferate market growth during the forecast period. Consumers are increasingly more concerned about the quality and safety of their food, and they also expect animal products to be free of toxins and diseases. To prevent and cure bacterial infections in livestock, the use of antibiotics in animal production might help assure the safety of the food.

Access to veterinary care and medications, including antibiotics, is improved by the growth of veterinary services, hospitals, and clinics, especially in emerging economies. The veterinary antibiotics industry is expanding as a result of easier accessibility and convenience.

Key Takeaways from Veterinary Antibiotics Market Report:

  • In 2022, the global market size stood at USD 10,911.5 million.
  • In 2022, tetracyclines segment captured 48.20% of global market shares.
  • In 2022, the premixes segment captured 46.10% of global market shares.
  • North America held 35.6% shares in the global veterinary antibiotics market in 2022.
  • Asia Pacific is projected to thrive at a CAGR of 5.4% from 2023 to 2033.

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!

Recent Developments Observed by FMI:

  • The ‘Nandi’ Portal was launched in June 2023 to allow online licensing of novel veterinary medications and vaccinations in India. New Drug and Immunization Device Approval is referred to by the abbreviation Nandi. The entire form makes it clear that Nandi wants to make it simpler for innovative veterinary drugs and vaccines to get NOCs.
  • To improve public and animal health in the country, the Indian Pharmacopoeia Commission (IPC) approved seven new veterinary monographs and eight new chemical monographs for the Indian Pharmacopoeia (IP) 2022. The recently approved veterinary monographs include Carprofen tablets, Pimobendan capsules, Selamectin, Tilmicosin, Tilmicosin injectable, and Triclabendazole.
  • In June 2021, the Pride Veterinary Medical Community and the American company Covetous, which specializes in animal health technologies, announced their collaboration. Covetous is located in the United States. This collaboration allows Covetrus to provide cutting-edge veterinary care, empowering veterinary healthcare professionals in the process.

Key Players in the Global Market:

  • Zoetis Inc.
  • Merck & Co.
  • Bayer AG
  • Sanofi
  • Eli Lilly and Company
  • Ceva Sante Animale

Veterinary Antibiotics Market Segmentation:

By Product Type:

  • Tetracyclines
  • Penicillins
  • Macrolides
  • Sulphonamides
  • Aminoglycosides
  • Others

By Route of Administration:

  • Premixes
  • Injections
  • Oral Powders
  • Oral Solutions
  • Others

By Animal Type:

  • Food-processing Animals
  • Companion Animals

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube 

Analyzing the Market Trends and Growth Drivers of the Buttermilk Powder Market and Future Opportunities

Buttermilk Powder Market
Buttermilk Powder Market

According to Future Market Insights (FMI), the global buttermilk powder market is valued at USD 2.7 billion in 2024 and it is anticipated to reach USD 3.8 billion by 2034. Over the next decade, global buttermilk powder demand is likely to increase at a CAGR of 3.5%.

The buttermilk powder market is witnessing significant growth, driven by its versatility and functional benefits that cater to a broad spectrum of industries. Derived from the liquid by-product of butter production, buttermilk powder retains the nutritional benefits and tangy flavor of traditional buttermilk while offering advantages such as extended shelf life, convenience in storage, and ease of transportation.

In the food and beverage industry, buttermilk powder is a valued ingredient due to its ability to enhance flavor, texture, and nutritional profile. It is widely used in bakery products, including cakes, cookies, pancakes, and bread, where it improves moisture retention, imparts a tender crumb, and enriches the taste. Additionally, it serves as a critical component in sauces, dressings, soups, and marinades, providing a creamy texture and rich flavor.

In dairy products, such as ice cream, cheese, and yogurt, buttermilk powder contributes to consistency, creaminess, and an appealing taste profile. The cosmetic industry leverages the moisturizing and exfoliating properties of buttermilk powder. It is incorporated into a variety of skincare products, including facial masks, lotions, creams, and soaps, where it helps to soften, hydrate, and rejuvenate the skin.

The natural acidity and lactic acid content in buttermilk powder makes it an effective ingredient for brightening, smoothing, and exfoliating the complexion, promoting a healthier and more radiant appearance. In the animal feed industry, buttermilk powder is utilized as a nutritious supplement. Rich in proteins, vitamins, and essential nutrients, it enhances the diet of livestock, contributing to better growth rates, improved health, and higher-quality produce.

Its inclusion in animal feed formulations supports the overall well-being of animals, making it a valuable component in the agriculture sector. Buttermilk powder finds applications in the food processing industry as a functional ingredient in ready-to-eat meals, snack foods, and beverages. Its ability to act as an emulsifier, stabilizer, and flavor enhancer makes it a preferred choice for food manufacturers aiming to improve product quality and appeal.

Key Takeaways from the Buttermilk Powder Market Report:

  • The global buttermilk powder market is expected to reach a valuation of USD 3.8 billion by 2034.
  • Global demand for buttermilk powder is likely to soar at a 3.5% CAGR over the forecast period.
  • By Product Type, spray-dried buttermilk powder is likely to exhibit a 7.8% CAGR during the projection period.
  • Europe is projected to hold a dominant value share of 27.8% in the global market by 2034.
  • The United States buttermilk powder market is estimated to witness a value CAGR of 4.7% during the projection period.

“The buttermilk powder market is set to flourish as industries increasingly recognize its multifaceted benefits. With applications spanning from enhancing the texture and flavor of bakery products to enriching skincare formulations and boosting animal nutrition, buttermilk powder is becoming a cornerstone ingredient. This market growth is propelled by the rising demand for natural, functional ingredients and the convenience offered by buttermilk powder’s extended shelf life. As consumer trends continue to favor health and sustainability, we can anticipate a robust expansion driven by innovative uses and cross-industry collaborations.” – Nandini Roy Choudhury, Client Partner at Future Market Insights 

Who is Winning?

Hoogwegt Group, All American Foods, Contenental Dairy Facilities, LLC, Agropur, Fonterra Co-operative Group Limited, DFA Ingredients solutions, IPS-Ingredis, North Cork Creameries, Lactalis Ingredients are the key Buttermilk Powder manufacturers listed in the report.

These companies are mainly focusing on strengthening and expanding their market by launching new products. They are also using strategies such as partnerships, advertisements, acquisitions, agreements, and mergers to stay competitive in the market.

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global buttermilk powder market presenting historical demand data (2019 to 2022) and forecast statistics for the period from 2023 to 2033.

The study incorporates compelling insights on the buttermilk powder market based on product type (atmospheric roller dried and spray dried) and Sales Channel (B2B and B2C) across various regions.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Growth and Trends in the Pet Food Premix Market: A Comprehensive Analysis

The global pet food premix market is estimated to reach a market valuation of USD 2,654.3 million in 2024. Over the forecast period, global pet food premix demand is expected to surge at a 5.1% CAGR. By 2034, the total market is projected to reach a USD 4,008 million valuation.

Rising consumer awareness about the connection between pets and their owners is driving increased demand for protein-based products for pets, alongside intensifying animal farming practices. Pet owners now seek foods that mirror current human food trends in nutrition and health.

Understanding the use of ingredients such as vitamins, minerals, trace elements, and other essential components in pet food premix products, and the trend towards ingredient transparency, aligns with predominant consumer demand for clean labels and a desire to know what goes into their pets’ food.

Many serious illnesses in pets result from inadequate intake of vitamins and minerals, leading to a weakened immune system and increased susceptibility to various diseases. Ensuring proper nutrition is crucial for the healthy growth of pets, benefiting their overall health by providing essential vitamins and minerals in their food.

Future Market Insights (FMI) reports a significant surge in the Food Premix Market, driven by increasing consumer demand for fortified and convenient nutrition solutions. This growth is fueled by advancements in premix formulations and rising health awareness globally

The pet food premix industry is experiencing significant growth, driven by increasing demand for high-quality and nutritious pet food products. Sales of pet food premixes are projected to rise as pet owners seek customized and balanced diets for their pets. The market’s value is forecasted to expand, supported by advancements in pet nutrition and rising pet ownership rates globally. This growth trend is expected to continue, with a strong emphasis on health and wellness in pet care

Key Takeaways from the Global Pet Food Premix Study:

  • The pet food premix market is projected to progress at a CAGR of 5.1% during the forecast period.
  • The United States pet food premix market is expected to develop at a 4.6% CAGR during the forecast period.
  • Based on form, the dry form segment is expected to dominate the pet food premix market with a 36% market share in 2024.
  • Based on ingredient type, the vitamin segment is expected to hold a leading market share of 32%, aiming for a market valuation of USD 849.3 million in 2024.

“Pet food premix market players who invest efficiently in research and development and marketing are likely to generate higher sales than their competitors owing to their strong brand positioning,” – Nandini Roy Choudhury, Client Partner at Future Market Insights.

Competition Outlook

The pet food premix market comprises several significant big and small players. Though significant, there are no dominant single players. Brands are focusing on enhancing their production capacity and supply chain to cater to a wider audience. The players are establishing collaborations and partnerships among themselves to innovate products as per the customer appeal.

Strategies such as diversifying product range in terms of various formats and being available on multiple sales channels are proving to be leaders.

Industry Updates

  • In May 2023, DSM, a global health and nutrition company focused on purpose, revealed its intention to construct a state-of-the-art nutritional premix plant in Tonganoxie, Kansas. The new facility aims to supply the pet food industry with top-tier nutritional premixes for use in branded pet food products worldwide, with full operational readiness expected by early 2025.
  • In February 2023, Evonik introduced its inaugural plant-based premix, PhytriCare® IM, designed to support animal health. This new product utilizes selected plant extracts rich in flavonoids, renowned for their anti-inflammatory properties. PhytriCare® IM is now accessible across the EU, with approval processes underway in other countries.

Leading Pet Food Premix Brands

  • ADM
  • DSM
  • Wisium
  • Zinpro
  • Alltech
  • Trouw Nutrition
  • MIAVIT
  • Koudijs
  • Premier Nutrition
  • AVITASA
  • Nutri-Science
  • MG3MIX
  • D&D Ingredient
  • Cargill Provimi
  • Jubilant Ingrevia
  • Others

Get valuable Insights into the Global Pet Food Premix Market

Future Market Insights, in its new offering, provides a thorough, detailed, and unbiased analysis of the global pet food premix market, presenting historical demand data for the years 2019 to 2023 and forecast statistics for the years 2024 to 2034.

The study categorizes valuable insights into the global pet food premix. Segmented by pet type, the market has been categorized into dogs, cats, fish, bird, rabbit, and others. By ingredient types, the industry is branched into vitamins, amino acids, minerals, lipids, and others. By form, the industry is further categorized into dry and liquid

Different sales channels include store-based retailing, hypermarkets/supermarkets, convenience stores, mom & pop stores, pet food stores, independent grocery retailers, other retail formats and online retailers.

By Region, industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Exploring the Rapid Growth of the Natural Dog Treat Market and Consumer Demand

The global Natural Dog Treat Market is poised for significant growth over the next decade, according to a new report by Future Market Insights. With increasing consumer awareness surrounding pet health, the demand for natural and premium-quality dog treats is projected to reach unprecedented levels. The global natural dog treat market is poised to reach a value of USD 4,374.6 million in 2024 and USD 6,844.8 million by 2034. Global sales of dog food will likely surge at a CAGR of 5.1% over the assessment period.

Key Market Drivers:

  1. Health-Conscious Pet Owners: As more pet owners focus on the nutritional content and safety of their pets’ diets, there is a growing shift toward natural and chemical-free dog treats. Natural dog treats, free from artificial additives, preservatives, and allergens, are increasingly favored for maintaining pet health and wellness.
  2. Rise in Pet Humanization: The trend of treating pets as part of the family continues to gain momentum, leading to a surge in demand for premium-quality pet food and treats. Pet owners are willing to invest in high-quality, healthy alternatives that mirror human-grade ingredients.
  3. Sustainability and Ethical Sourcing: Consumers are also prioritizing products that are not only beneficial for their pets but also ethically sourced and environmentally sustainable. This shift is fueling the adoption of eco-friendly packaging and ingredients in natural dog treats.

Market Segmentation and Growth Prospects:

  • Product Type: The report highlights a wide range of product offerings, including chewable treats, biscuits, jerky, and freeze-dried snacks, with the chewable segment expected to dominate the market by 2034.
  • Sales Channels: Online sales platforms, retail stores, and specialty pet stores continue to play a critical role in the distribution of natural dog treats. E-commerce channels are anticipated to witness rapid growth due to convenience and accessibility.

Regional Insights:

North America is expected to lead the market with a strong presence of pet care companies and increasing expenditure on pet health. The U.S. and Canada are projected to experience steady growth due to high pet ownership rates and premium product demand.

Meanwhile, Europe and Asia-Pacific are also witnessing increasing adoption of natural dog treats. The European market is driven by stringent regulations around pet food safety, while the Asia-Pacific market benefits from rising disposable incomes and growing pet adoption rates in countries such as China and Japan.

Competitive Landscape:

Key players in the market, including brands such as Blue Buffalo, Nestlé Purina PetCare, and Mars Petcare, are focusing on product innovation, organic ingredient sourcing, and strategic collaborations to strengthen their market positions. Start-ups and niche brands are also gaining traction, offering unique and specialized natural dog treats.

Industry Updates

  • In May 2024, Dr. Clauder’s launched the world’s first dog treats made using FeedKindPet, which is an air protein-derived ingredient that can be a potential ingredient for natural dog treats.
  • In June 2024, Carthage offered healthy, homemade dog treats made with natural ingredients like oats, pumpkin puree, and organic peanut butter. Variations are also offered with the use of strawberries and blueberries, serving the different health requirements of dogs. The product is receiving positive feedback from pet owners due to its health benefits and affordable pricing.

Leading Natural Dog Treats Brands

  • Petmex Company Sp. z o.o.
  • AOV Group
  • Zenta Pets
  • Dog Crunchies
  • Beg & Barker
  • Packnpride
  • The Dog Chew Company
  • NürnbergMesse GmbH
  • Oh Crap
  • Blue Buffalo Company, Ltd.
  • Others

Key Segments of Market Report

By Product Type:

As per product type, the sector has been categorized into bully sticks, ears, gullets, bones, legs, and others.

By Age:

In terms of age, the target sector is categorized into puppies, adult, and seniors.

By Distribution Channel:

Different distribution channels include hypermarkets/supermarkets, convenience stores, drugstores, and online retailers.

By Application:

The industry has been segmented into stronger immunity, better digestion, dental and oral health support, fewer allergies, and others.

By Protein Type:

When it comes to protein type, the global industry is categorized into beef, pork, chicken, rabbit, lamb, and others.

By Region:

Industry analysis has been carried out for key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Emerging Trends and Market Insights in the Chickpea Milk Market and Future Opportunities

The global chickpea milk market size is estimated to reach USD 189.3 million in 2024 and USD 301.5 million by 2034. Global sales of chickpea milk will likely soar at a CAGR of 4.8% during the assessment period.

The chickpea milk market is gaining traction as health-conscious consumers shift towards plant-based alternatives to traditional dairy products. Derived from chickpeas, this dairy alternative offers a rich source of protein, vitamins, and essential nutrients while being free of lactose, gluten, and cholesterol. With the growing focus on environmental sustainability and dietary inclusivity, chickpea milk is rapidly becoming a popular choice across diverse demographics.

Chickpea milk, also known as garbanzo milk, is becoming a popular plant-based milk with diverse nutritional and environmental advantages. Rising awareness about the benefits of this plant-based milk is expected to boost sales growth during the forecast period.

Key Drivers of Growth

  1. Rising Popularity of Plant-Based Diets

The global rise in veganism and flexitarian diets has led to increased demand for plant-based dairy alternatives. Chickpea milk, with its creamy texture and high nutritional content, is emerging as a strong contender in the dairy-free beverage sector.

  1. Health and Nutritional Benefits

Chickpea milk is packed with plant-based proteins, vitamins (such as B6), and essential minerals like iron and magnesium. It supports heart health, promotes digestive wellness, and caters to consumers with lactose intolerance or gluten sensitivity, making it a versatile choice.

  1. Sustainability Advantage

Compared to almond or soy milk, chickpea milk requires less water and land to produce, making it a more eco-friendly alternative. This aligns with consumer and corporate goals of reducing environmental footprints, boosting its appeal in the market.

  1. Innovations and Product Diversification

Brands are introducing innovative chickpea milk products with varied flavors, fortified nutrients, and specialized formulations for different consumer groups, such as athletes, children, and seniors. These innovations are expanding the market and attracting new buyers.

Key Takeaways

  • The global chickpea milk market is projected to grow at a CAGR of 4.8% between 2024 and 2034.
  • Health benefits, sustainability, and versatility are driving its popularity across beverages, culinary uses, and functional foods.
  • North America and Europe are the leading markets, with significant growth expected in Asia-Pacific.
  • Innovations and increased awareness will be pivotal in overcoming market challenges.

Regional Market Insights

North America

The United States and Canada are leading markets due to high adoption of plant-based diets and growing consumer awareness about environmental sustainability.

Europe

Countries like Germany, the UK, and France are experiencing a surge in demand for dairy alternatives, driven by dietary preferences and government initiatives supporting plant-based food innovation.

Asia-Pacific

Emerging economies like China and India offer lucrative opportunities, with increasing urbanization, rising disposable incomes, and growing health awareness fueling the adoption of chickpea milk.

Latin America and MEA

The market is gradually growing in these regions, supported by expanding distribution networks and consumer interest in healthy and sustainable food options.

Competition Outlook

The chickpea milk market encompasses a diverse and dynamic competitive landscape. Leading companies are focusing on research and development, creating new formulations, and sustainable sourcing. Players are also looking to employ environment-friendly practices to satisfy the increasing demand for natural and sustainable ingredients.

Several companies are using innovative packaging to attract customers. Similarly, strategies like celebrity endorsements, partnerships, collaborations, and distribution agreements are becoming prevalent in the industry.

Industry Updates

  • In February 2024, Califia Farms, a prominent plant-based beverage brand, introduced Califia Farms Complete, a creamy plant milk made from a special blend of fava bean protein, pea, and chickpea.
  • In 2024, Yofiit’s new chickpea milk made its way into the American market, offering consumers plant-based alternatives.

Leading Chickpea Milk Brands

  • Yofi
  • Yofiit
  • EPIC’C (Growth Well)
  • Tally Foods Inc.
  • Star Plants
  • Califia Farms
  • Others

Key Segments of Chickpea Milk Market Report

By Category:

As per category, the industry has been categorized into organic, and conventional.

By Flavor:

In terms of flavor, the chickpea milk market has been categorized into original/unflavored, and flavored. The flavored segment is further divided into chocolate, vanilla, strawberry, blueberry, and others.

By End Use:

Based on end use, the sector is segmented into dairy products, bakery and confectionery, and milk based beverages. The dairy products segment is further categorized into milk, cheese, yogurt, butter, ice cream, and frozen dessert.

By Region:

Chickpea milk industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Key Drivers and Trends Shaping the Medical Nutrition Market’s Growth and Future Opportunities

The global Medical Nutrition Market is forecasted to experience substantial growth between 2024 and 2034, according to a comprehensive report by Future Market Insights. With an increasing emphasis on therapeutic nutrition for managing chronic diseases, aging populations, and critical care needs. Global Medical Nutrition industry sales reached approximately USD 16,192.6 million at the end of 2024. Forecasts suggest the market will achieve a 6.4% compound annual growth rate (CAGR) and exceed USD 26,555.9 million in value by 2034

Key Drivers of Market Growth:

  1. Rising Prevalence of Chronic Diseases: The global burden of diseases such as diabetes, cancer, cardiovascular diseases, and gastrointestinal disorders is driving demand for specialized medical nutrition solutions. These products are designed to support patient recovery, improve clinical outcomes, and enhance quality of life by providing targeted nutrition tailored to specific health conditions.
  2. Aging Population: As the world’s aging population continues to grow, the need for tailored nutritional products is increasing. Elderly individuals often face malnutrition and require specific formulations to support their health and recovery, particularly in long-term care facilities and hospitals.
  3. Advances in Clinical Nutrition: Innovations in medical nutrition products, including enteral and parenteral nutrition solutions, are revolutionizing patient care. These products are increasingly used in hospitals, clinics, and home healthcare settings to manage malnutrition and provide essential nutrients for patients who are unable to consume regular food.

Market Segmentation and Key Applications:

  • Product Types: The report highlights enteral nutrition and parenteral nutrition as the two major segments of the medical nutrition market. Enteral nutrition is expected to dominate the market due to its widespread use in critical care and home healthcare settings.
  • Application Areas: Medical nutrition products are being widely used in oncology, diabetes, gastrointestinal diseases, critical care, and other therapeutic areas. The oncology segment is projected to witness significant growth as cancer patients require specialized nutrition to combat malnutrition and support treatment recovery.

Regional Outlook:

North America is expected to lead the global medical nutrition market, driven by a well-established healthcare infrastructure, high awareness of therapeutic nutrition, and strong demand for disease-specific nutritional products. The United States, in particular, continues to be a major market, supported by an aging population and high prevalence of chronic diseases.

Europe is also a key player in the medical nutrition market, with countries like Germany, France, and the UK experiencing increased adoption of specialized nutrition products in hospitals and clinics. In addition, the Asia-Pacific region is expected to witness significant growth over the next decade, supported by rising healthcare expenditure and a growing number of elderly patients in countries such as Japan and China.

Competitive Landscape:

The global medical nutrition market is highly competitive, with key players including Abbott Nutrition, Nestlé Health Science, Danone, Fresenius Kabi, and Baxter International leading the market. These companies are focusing on product innovation, research and development, and strategic partnerships to enhance their market presence.

New entrants and niche players are also gaining traction by offering personalized medical nutrition solutions and targeting specific therapeutic areas. The ongoing focus on innovation and patient-centered care is expected to shape the future of the medical nutrition market.

For example:

In 2022, a partnership between Danone and Bioiberica was established to develop and commercialize nutritional solutions for musculoskeletal health, specifically osteoarthritis. The deal allows Bioiberica to leverage its extensive clinical expertise while Danone could bring its scientific know-how and other competencies to provide proper medical nutrition solutions that meet the needs of patients suffering from movement-related problems associated with aging populations

Leading Medical Nutrition Brands

  • Zeon Lifesciences Ltd.
  • Nestle
  • GSk plc
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Abbott
  • Danone S.A
  • BASF SE
  • Fresenius SE & Co
  • KGaA
  • Leprino Foods Company
  • Fresenius Kabi Ltd
  • Esperer Onco Nutrition
  • Kate Farms
  • Guardion Health Sciences
  • DSM
  • Baxter

Key Segments of Market Report

By Nutrition Type:

As per By Nutrition Type, the segment has been categorized into Proteins, Carbohydrates, Multivitamins & Antioxidant, Amino acids, Fiber, Mineral and others.

By Health Condition:

Health Conditions included Cancer, Diebties, Gastrointestinal disease, metabolic syndrome, and others

By Patient Type:

This segment is further categorized into infant, adult, and Geriatric

By Mode of Delivery:

The modes of delivery include Oral, Enteral, and Parenteral

By Sales Channel:

Different Sales channels include Store-based Retailing, (Hypermarkets & Supermarkets, Convenience Store, Drug Stores & Pharmacies, Specialty Stores, and Other Retailers) and Online Retailing

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global General Surgery Devices Market Set to Surge with Projected Valuation of USD 23.6 Billion by 2033: Future Market Insights

According to Future Market Insights’ most recent industry report, the global general surgery devices market valued at around USD 12.0 billion in 2023 and is set to grow at a CAGR of 6.4% over the forecast period, reaching a projected valuation of USD 23.6 billion in 2033.

One of the key reasons for the expanding usage of laparoscopic operations on a global scale is the rising frequency of numerous serious illnesses such as colorectal cancer and gynecological disorders. Because of the numerous advantages provided by minimally invasive treatments, there is an increase in demand for minimally invasive operations.

Laparoscopy being a minimally invasive procedure that enables the doctor to get to the inner parts of the abdomen (tummy) and pelvis without making deep cuts in the skin, the rising demand for minimally invasive procedures can boost market growth.

The requirement of surgical procedure is in high demand due to advancements in the treatments. For example, laparoscopic surgery will continue to collaborate with more computer-assisted technology, more image-based technology, and the creation of new energy devices to reduce costs. As a result of the cheaper cost of the treatments, there will be a lucrative demand for general surgeries.

Key Takeaways from Market Study:

  • Direct energy system devices are the leading segment as product, and held around 28.2% market value share in 2022, owing to aesthetically minimizing wounds and allowing doctors to conceal scars.
  • Colorectal surgery segment is set to lead among application segment of general surgery devices market with a projected market value share of around 29.7% by 2033, owing to the rising prevalence of colorectal cancer
  • By end user, hospitals held a share of around 74.2% in 2022 due to preference of patient to visit hospitals for surgical procedures compared to other end user settings.
  • North America held a value share of around 30.4% in 2022, due to rising surgeries of colorectal cancer in the region.

“Growing Demand for Minimally Invasive Surgeries among the ever increasing Patient Pool suffering from Chronic Conditions is set to propel the Global Market for General Surgery Devices,” says an analyst of Future Market Insights.

Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Market Competition:

The general surgery devices market is a sector that has undergone consolidation. The market participants are concentrating on creating and introducing technologically enhanced approaches in order to increase the accuracy and efficiency of the operations and reduce post-operative problems.

  • The commercial debut of Smith & Nephew’s CORI Surgical System, the company’s newest portable robotics platform, in Japan is scheduled for February 2022.
  • To provide complete technology and product options in urology, gynecology, and general surgery, Arthrex and Richard Wolf, worldwide pioneers in minimally invasive surgical technologies and solutions, announced a U.S.-based cooperation in November 2022.

Key Companies Profiled:

  • Janssen Pharmaceutical
  • Medtronic Plc
  • Becton, Dickinson and Company
  • Olympusm Corporation
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Smith & Nephew Plc
  • KARL STORZ GmbH & Co. KG
  • Richard Wolf GmbH
  • CooperSurgical, Inc.
  • Intuitive Surgical Inc
  • Endocontrol SA
  • Hangzhou Kangji Medical Instrument Co., Ltd
  • Zhejiang Geyi Medical Instrument Co., Ltd

Key Market Segments Covered in the General Surgery Devices Industry Research:

Product:

  • Direct Energy System Devices
  • Trocars/Access Device
  • Internal Closure Devices
  • Laparoscopes
  • Hand Access Instruments
  • Insufflation Devices
  • Robotic Assisted Surgical System

Applications:

  • Bariatric Surgery
  • Colorectal Surgery
  • General Surgery
  • Gynaecological Surgery
  • Other Surgery

End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Bone Grafts and Substitutes Market Set for Significant Growth, Expected to Reach USD 6.3 Billion by 2032 with a projected CAGR of 7.1% | FMI

“North America holds over 40% of the Bone Grafts and Substitutes Market, driven by growing demand for dental bone grafts and successful implant surgeries.”

The global bone grafts and substitutes market valued at USD 3.2 billion in 2022, is on track to experience substantial growth, with projections indicating it will reach USD 6.3 billion by 2032. This growth is highlighted in a recent market survey conducted by Future Market Insights (FMI), which identifies key trends and growth drivers within the market.

The spinal fusion segment is poised to be the leading driver of this growth, accounting for a significant portion of the market revenue. The deployment model for spinal fusion procedures is expected to register a compound annual growth rate (CAGR) of 7.1% by 2032, driven by the rising prevalence of spinal cord injuries (SCI) worldwide. As the demand for spinal fusion surgeries increases, so too does the need for effective bone grafts and substitutes to support the healing process and improve patient outcomes.

The US to Command the Larger Proportion of Bone Grafts and Substitutes Market throughout the Analysis Period:

The US commands 37.3% of the market share and is expected to maintain the position intact with an absolute opportunity growth of USD 1.2 Billion to reach a valuation of USD 2.4 Billion by 2032. Owing to the rapidly increasing requirement for bone grafts and substitutes in Spinal Cord Injuries (SCIs) cases, its demand in the US is expected to increase.  A CDC report has anticipated 67 Million adults in the country to be arthritis patients by 2030, which will increase the demand for bone grafts since it is an essential requirement for arthritis treatment.

“The application of allograft bone grafts in demineralized bone matrices procedures have significant potential to emerge as a key market driver during the forecast period for the Bone Grafts and Substitutes market.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Key Takeaways from the Global Bone Grafts and Substitutes Market: Market Growth:

The global bone grafts and substitutes market is set for impressive growth, with projections indicating an increase from USD 3.2 billion in 2022 to USD 6.3 billion by 2032. This surge in market value is driven by a rising demand for spinal fusion procedures and an increasing number of spinal cord injury (SCI) cases worldwide.

Spinal Fusion: A Key Market Driver

A major contributor to the growth of the bone grafts and substitutes market is the spinal fusion segment. With an anticipated compound annual growth rate (CAGR) of 7.1% by 2032, the need for effective bone grafts to support spinal fusion surgeries is expected to expand as SCI rates continue to rise globally.

Asia-Pacific Region Leads with Growth Potential:

The Asia-Pacific region, led by China and India, is experiencing a surge in the market, fueled by cost-effective synthetic bone grafts and the rise of dental medical tourism. China is forecasted to grow at a CAGR of 9%, reaching USD 475.5 million by 2032. Japan’s market is also on track for significant growth, projected to increase at a 9.2% CAGR, reaching USD 367.8 million by 2032. This growth is driven by technological advancements in the field, such as Medtronic’s Grafton DBM. Meanwhile, India is also seeing innovation with new bone graft substitutes like PoroSyn and SynOst, developed by the National Chemical Laboratory, which are expected to support market growth.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

North America: Dominant Market with Steady Growth

North America holds over 40% of the global bone grafts and substitutes market share, and it is expected to maintain its dominant position in the coming years. The USA, in particular, is experiencing substantial growth driven by the increasing demand for dental bone grafts, with approximately 5 million dental implant surgeries conducted annually. The market in the USA is projected to grow at a 6.9% CAGR, reaching USD 2.4 billion by 2032. This growth is further propelled by the rising incidence of joint disorders, sports injuries, and spinal cord injury cases, all of which require effective bone grafting solutions.

Key Growth Drivers in the USA

The success of dental implant surgeries and the rising prevalence of joint disorders, including arthritis, are major factors fueling the demand for bone grafts. According to the CDC, 67 million adults in the USA are projected to be diagnosed with arthritis by 2030, significantly increasing the need for bone grafts as a treatment solution.

Conclusion: Robust Market Outlook

The bone grafts and substitutes market is on track for significant expansion, driven by increased demand for spinal fusion surgeries, dental implants, and innovations across the Asia-Pacific region. North America, particularly the USA, remains a dominant force, supported by a growing number of surgical procedures and a rising need for effective bone grafting solutions. With a robust growth trajectory, the market is well-positioned for substantial developments over the next decade.

Bone Grafts and Substitutes Market: Competition Insights

Currently, Bone Grafts and Substitutes providers are largely aiming at adopting strategies such as mergers, acquisitions, and partnerships. They are working towards finding a balance between expanding their product portfolio and capitalizing on the growing market demand. The key companies operating in the Bone Grafts and Substitutes market include Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, and SeaSpine.

The Key Recent Developments of Bone Grafts and Substitutes Manufacturers are as Follows:

  • In February 2022, Opus B.A., a highly efficient and synthetic bioactive bone graft solution, was launched by Orthofix Medical Inc. to benefit the process of cervical and lumbar spine fusions.
  • In February 2021, Simplify Medical was amassed by NuVasive Inc. to strengthen the company’s cervical portfolio, thus expanding its growth avenues during the forecast period.
  • In November 2020, the acquisition of Wright Medical Group N.V. was finalized by Stryker Corporation. The amassing of this medical equipment enterprise specializing in extremities and biologics is anticipated to aid in the enhancement of Stryker Corporation’s bone graft substitute portfolio, in order to expand its position in the market.
  • In July 2020, the FDA approved the Altapore Shape bioactive bone graft, by Baxter. The specific attributes of this bone graft among many include enhanced bone growth.

Key Segments Covered in Market Survey:

The Bone Grafts and Substitutes Market is segmented based on material type, deployment mode, and region.

By Material Type:

  • Allograft
    • Demineralized Bone Matrix
    • Other Allografts
  • Synthetic
    • Ceramics
    • Composites
    • Polymers
    • Bone Morphogenic Proteins (BMP)

By Deployment Mode:

  • Craniomaxillofacial
  • Dental
  • Foot & Ankle
  • Joint Reconstruction
  • Long Bone
  • Spinal Fusion

By Region:

  • North America
  • Asia Pacific
  • Europe
  • The Middle East and Africa (MEA)
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube